文献
J-GLOBAL ID:202002221295605761
整理番号:20A2135361
血液悪性腫瘍の免疫ゲノム景観【JST・京大機械翻訳】
Immunogenomic Landscape of Hematological Malignancies
著者 (41件):
Dufva Olli
(Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center (HUH CCC), 00029 Helsinki, Finland)
,
Dufva Olli
(Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki (UH), 00029 Helsinki, Finland)
,
Dufva Olli
(iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland)
,
Polonen Petri
(Institute of Biomedicine, School of Medicine, University of Eastern Finland, 70211 Kuopio, Finland)
,
Brueck Oscar
(Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center (HUH CCC), 00029 Helsinki, Finland)
,
Brueck Oscar
(Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki (UH), 00029 Helsinki, Finland)
,
Brueck Oscar
(iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland)
,
Keraenen Mikko A.I.
(Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center (HUH CCC), 00029 Helsinki, Finland)
,
Keraenen Mikko A.I.
(Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki (UH), 00029 Helsinki, Finland)
,
Klievink Jay
(Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center (HUH CCC), 00029 Helsinki, Finland)
,
Klievink Jay
(Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki (UH), 00029 Helsinki, Finland)
,
Mehtonen Juha
(Institute of Biomedicine, School of Medicine, University of Eastern Finland, 70211 Kuopio, Finland)
,
Huuhtanen Jani
(Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center (HUH CCC), 00029 Helsinki, Finland)
,
Huuhtanen Jani
(Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki (UH), 00029 Helsinki, Finland)
,
Kumar Ashwini
(Institute for Molecular Medicine Finland, UH, 00014 Helsinki, Finland)
,
Malani Disha
(Institute for Molecular Medicine Finland, UH, 00014 Helsinki, Finland)
,
Siitonen Sanna
(Department of Clinical Chemistry, UH and HUSLAB, HUH, 00029 Helsinki, Finland)
,
Kankainen Matti
(Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center (HUH CCC), 00029 Helsinki, Finland)
,
Kankainen Matti
(Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki (UH), 00029 Helsinki, Finland)
,
Kankainen Matti
(iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland)
,
Ghimire Bishwa
(Institute for Molecular Medicine Finland, UH, 00014 Helsinki, Finland)
,
Lahtela Jenni
(Institute for Molecular Medicine Finland, UH, 00014 Helsinki, Finland)
,
Mattila Pirkko
(Institute for Molecular Medicine Finland, UH, 00014 Helsinki, Finland)
,
Vaehae-Koskela Markus
(Institute for Molecular Medicine Finland, UH, 00014 Helsinki, Finland)
,
Wennerberg Krister
(Institute for Molecular Medicine Finland, UH, 00014 Helsinki, Finland)
,
Granberg Kirsi
(Laboratory of Computational Biology, Faculty of Medicine and Health Technology, Tampere University (TU), 33014 Tampere, Finland)
,
Leivonen Suvi-Katri
(Department of Oncology, HUH CCC, 00029 Helsinki, Finland)
,
Leivonen Suvi-Katri
(Applied Tumor Genomics Research Program, Faculty of Medicine, UH, 00014 Helsinki, Finland)
,
Meriranta Leo
(Department of Oncology, HUH CCC, 00029 Helsinki, Finland)
,
Meriranta Leo
(Applied Tumor Genomics Research Program, Faculty of Medicine, UH, 00014 Helsinki, Finland)
,
Heckman Caroline
(iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland)
,
Heckman Caroline
(Institute for Molecular Medicine Finland, UH, 00014 Helsinki, Finland)
,
Leppae Sirpa
(iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland)
,
Leppae Sirpa
(Department of Oncology, HUH CCC, 00029 Helsinki, Finland)
,
Leppae Sirpa
(Applied Tumor Genomics Research Program, Faculty of Medicine, UH, 00014 Helsinki, Finland)
,
Nykter Matti
(Laboratory of Computational Biology, Faculty of Medicine and Health Technology, Tampere University (TU), 33014 Tampere, Finland)
,
Lohi Olli
(Tampere Center for Child Health Research, TU and Tays Cancer Center, Tampere University Hospital, 33521 Tampere, Finland)
,
Heinaeniemi Merja
(Institute of Biomedicine, School of Medicine, University of Eastern Finland, 70211 Kuopio, Finland)
,
Mustjoki Satu
(Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center (HUH CCC), 00029 Helsinki, Finland)
,
Mustjoki Satu
(Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki (UH), 00029 Helsinki, Finland)
,
Mustjoki Satu
(iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland)
資料名:
Cancer Cell
(Cancer Cell)
巻:
38
号:
3
ページ:
380-399.e13
発行年:
2020年
JST資料番号:
W1844A
ISSN:
1535-6108
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)